BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioNJ - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bionj.org
X-WR-CALDESC:Events for BioNJ
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250731T093000
DTEND;TZID=America/New_York:20250731T110000
DTSTAMP:20260503T095804
CREATED:20250701T153626Z
LAST-MODIFIED:20250717T124138Z
UID:15948-1753954200-1753959600@bionj.org
SUMMARY:From Price Controls to Production Lines: How Policy Is Reshaping Biopharma Strategy
DESCRIPTION:Webinar: From Price Controls to Production Lines: How Policy Is Reshaping Biopharma Strategy \n\n\n\nThursday\, July 31 | 9:30 a.m.-11:00 a.m. | Free to BioNJ Members \n\n\n\n\nREGISTER TODAY!\n\n\n\n\n\n\nBioNJ and Manatt Health invite you to a high-impact webinar exploring how today’s policy environment is transforming the economics\, strategy and logistics of bringing therapies to market. With federal action on drug pricing reform and pharmaceutical supply chain security accelerating\, life sciences leaders must adapt to a new set of constraints — and opportunities.  \n\n\n\nThis session will bring together legal\, policy and market experts to examine how the policies like the Inflation Reduction Act (IRA)\, the Most-Favored Nation Executive Order\, Budget Reconciliation and the BIOSECURE Act are reshaping drug development timelines\, manufacturing strategies and commercialization risk. From pricing pressures and exclusivity reform to reshoring incentives and funding models\, we’ll explore how business leaders can position their organizations for resilience and growth. \n\n\n\nKey Takeaways: Whether you’re charting policy risks\, optimizing your supply chain or planning for long-term growth\, this webinar will provide the strategic context and actionable guidance you need to stay ahead.  \n\n\n\n\n\nTopics \n\n\n\nDrug Pricing Reform \n\n\n\n\nHow IRA implementation\, MFN-style pricing and reconciliation policy are impacting pricing dynamics\n\n\n\nThe exclusivity debate and its implications for innovation\, especially in rare diseases\n\n\n\nThe evolving role of PBMs and pending legislative reforms aimed at transparency and cost control\n\n\n\n\nSupply Chain Resilience \n\n\n\n\nThe risks of global dependencies and policy moves to strengthen U.S.-aligned manufacturing\n\n\n\nOpportunities and challenges in reshoring and rebalancing biopharmaceutical production\n\n\n\nQuality\, cost and sourcing trade-offs in a geopolitically complex landscape\n\n\n\nNew federal funding pathways and financing models to support domestic production\n\n\n\nEmerging risks from proposals like “Pharma-Ron” and how to engage proactively\n\n\n\n\nIntegrated Business Strategy \n\n\n\n\nWhy commercialization\, sourcing\, manufacturing and logistics planning must be aligned with evolving policy\n\n\n\nHow to build resilience across the value chain — from pricing strategy to Patient delivery\n\n\n\n\nSpeakers \n\n\n\n\n\n\n\n\n\nNicholas W. Bath\, Jr.PartnerManatt Health \n\n\n\n\n\n\n\n\n\nMichael S. KolberPartnerManatt Health \n\n\n\n\n\n\n\n\n\nMelindah SharmaManaging DirectorManatt Health \n\n\n\n\n\n\n\n\n\nWhether you’re a CEO\, SVP\, Commercial Ops lead\, legal advisor or corporate affairs executive\, this session is designed to provide the strategic clarity you need to navigate today’s challenges — and tomorrow’s opportunities. \n\n\n\nRegister today and join us on July 31 for this must-attend webinar on biopharma policy shifts. Registration is FREE to BioNJ Members and $75 for Future BioNJ Members.
URL:https://bionj.org/event/from-price-controls-to-production-lines-how-policy-is-reshaping-biopharma-strategy/
CATEGORIES:BioNJ Event
ATTACH;FMTTYPE=image/png:https://bionj.org/wp-content/uploads/2025/06/Manatt-Header.png
END:VEVENT
END:VCALENDAR